Nonsyndromic deafness is
hearing loss that is not associated with other signs and symptoms. In contrast, syndromic
deafness involves hearing loss that occurs with abnormalities in other parts of the body. Genetic changes are related to the following types of nonsyndromic deafness.
* DFNA: nonsyndromic deafness,
autosomal dominant
* DFNB: nonsyndromic deafness, autosomal recessive
* DFNX: nonsyndromic deafness,
X-linked
* nonsyndromic deafness,
mitochondrial
A mitochondrion (; ) is an organelle found in the cells of most Eukaryotes, such as animals, plants and fungi. Mitochondria have a double membrane structure and use aerobic respiration to generate adenosine triphosphate (ATP), which is use ...
Each type is numbered in the order in which it was described. For example, DFNA1 was the first described autosomal dominant type of nonsyndromic deafness. Mitochondrial nonsyndromic deafness involves changes to the small amount of
DNA found in mitochondria, the energy-producing centers within cells.
Most forms of nonsyndromic deafness are associated with permanent hearing loss caused by damage to structures in the inner ear. The inner ear consists of three parts: a snail-shaped structure called the
cochlea that helps process sound, nerves that send information from the cochlea to the brain, and structures involved with balance. Loss of hearing caused by changes in the inner ear is called
sensorineural deafness. Hearing loss that results from changes in the
middle ear is called conductive hearing loss. The middle ear contains three tiny
bones that help transfer sound from the eardrum to the inner ear. Some forms of nonsyndromic deafness involve changes in both the inner ear and the middle ear; this combination is called mixed hearing loss.
The severity of hearing loss varies and can change over time. It can affect one ear (unilateral) or both ears (bilateral). Degrees of hearing loss range from mild (difficulty understanding soft speech) to profound (inability to hear even very loud noises). The loss may be stable, or it may progress as a person gets older. Particular types of nonsyndromic deafness often show distinctive patterns of hearing loss. For example, the loss may be more pronounced at high, middle, or low
tones.
Classification
Nonsyndromic deafness can occur at any age. Hearing loss that is present before a child learns to speak is classified as
prelingual or congenital. Hearing loss that occurs after the development of speech is classified as
postlingual.
Genetics
Nonsyndromic deafness can have different patterns of inheritance. Between 75% and 80% of cases are inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. Usually, each parent of an individual with autosomal recessive deafness is a carrier of one copy of the altered gene. These carriers do not have hearing loss.
Another 20% to 25% of nonsyndromic deafness cases are autosomal dominant, which means one copy of the altered gene in each cell is sufficient to result in hearing loss. People with autosomal dominant deafness most often inherit an altered copy of the gene from a parent who has hearing loss.
Between 1% and 2% of cases show an X-linked pattern of inheritance, which means the mutated gene responsible for the condition is located on the X chromosome. Males with X-linked nonsyndromic deafness tend to develop more severe hearing loss earlier in life than females who inherit a copy of the same
gene mutation. Fathers will not pass X-linked traits to their sons since they do not pass on the X chromosome to their male offspring.
Mitochondrial nonsyndromic deafness, which results from changes to the DNA in mitochondria, occurs in fewer than 1% of cases in the United States. The altered mitochondrial DNA is passed from a mother to her sons and daughters. This type of deafness is not inherited from fathers.
Late onset progressive deafness is the most common neurological disability of the elderly. Although hearing loss of greater than 25 decibels is present in only 1% of young adults between the ages of 18–24 years of age, this increases to 10% in persons between 55 and 64 years of age and approximately 50% in octogenarians.
The relative contribution of heredity to age-related hearing impairment is not known, however the majority of inherited late-onset deafness is autosomal dominant and non-syndromic (Van Camp et al., 1997). Over forty genes associated with autosomal dominant non-syndromic hearing loss have been localized and of these fifteen have been cloned.
Genes related to nonsyndromic deafness
Mutations in the ''
ACTG1'', ''
CABP2
Frozen state pensions is the practice of the British Government of "freezing" UK State Pensions, (that is, not uprating the amount in line with "Triple Lock" on an annual basis, as is done for residents in the UK), for pensioners who live in t ...
'', ''
CDH23'', ''
CLDN14'', ''
COCH'', ''
COL11A2
Collagen alpha-2(XI) chain is a protein that in humans is encoded by the ''COL11A2'' gene.
The COL11A2 gene produces one component of this type of collagen, called the pro-alpha2(XI) chain. Type XI collagen adds structure and strength to the tissu ...
'', ''
DFNA5
Non-syndromic hearing impairment protein 5 is a protein that in humans is encoded by the ''DFNA5'' gene.
Function
Hearing impairment is a heterogeneous condition with over 40 loci described. The protein encoded by this gene is expressed in fet ...
'', ''
ESPN'', ''
EYA4'', ''
GJB2'', ''
GJB6'', ''
KCNQ4'', ''
MYO15A
Myosin-XV is a protein that in humans is encoded by the ''MYO15A'' gene.
Gene
Read-through transcript containing an upstream gene and this gene have been identified, but they are not thought to encode a fusion protein. Several alternativel ...
'', ''
MYO6'', ''
MYO7A
Myosin VIIA is protein that in humans is encoded by the ''MYO7A'' gene. Myosin VIIA is a member of the unconventional myosin superfamily of proteins. Myosins are actin binding molecular motors that use the enzymatic conversion of ATP - ADP + inor ...
'', ''
OTOF
Otoferlin is a protein that in humans is encoded by the ''OTOF'' gene.
Function
Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has three C2 domains, a single ...
'', ''
PCDH15'', ''
POU3F4
POU domain, class 3, transcription factor 4 is a protein that in humans is encoded by the ''POU3F4'' gene found on the X chromosome.
POU3F4 is involved in the patterning of the neural tube and both the paraventricular and supraoptic nuclei of t ...
'', ''
SLC26A4
Pendrin is an anion exchange protein that in humans is encoded by the ''SLC26A4'' gene (solute carrier family 26, member 4).
Pendrin was initially identified as a sodium-independent chloride-iodide exchanger with subsequent studies showing that ...
'', ''
STRC'', ''
TECTA'', ''
TMC1
Transmembrane channel-like protein 1 is a protein that in humans is encoded by the ''TMC1'' gene. TMC1 contains six transmembrane domains with both the C and N termini on the endoplasmic side of the membrane, as well as a large loop between domain ...
'', ''
TMIE'', ''
TMPRSS3
Transmembrane protease, serine 3 is an enzyme that in humans is encoded by the ''TMPRSS3'' gene.
Function
This gene encodes a member of the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, ...
'', ''
USH1C
Harmonin is a protein that in humans is encoded by the USH1C gene. It is expressed in sensory cells of the inner ear and retina, where it plays a role in hearing, balance, and vision. Mutations at the USH1C locus cause Usher syndrome type 1c ...
'', and ''
WFS1
Wolframin is a protein that in humans is encoded by the ''WFS1'' gene.
Function
This gene encodes a transmembrane protein, which is located primarily in the endoplasmic reticulum and ubiquitously expressed with highest levels in brain, pancre ...
'' genes cause nonsyndromic deafness, with weaker evidence currently implicating genes ''
CCDC50'', ''
DIAPH1'', ''
DSPP'', ''
ESRRB
Estrogen-related receptor beta (ERR-β), also known as ESRRB or NR3B2 (nuclear receptor subfamily 3, group B, member 2), is a nuclear receptor that in humans is encoded by the ''ESRRB'' (Estrogen Related Receptor Beta) gene
In biology, the ...
'', ''
GJB3
Gap junction beta-3 protein (GJB3), also known as connexin 31 (Cx31) — is a protein that in humans is encoded by the ''GJB3'' gene.
Function
This gene is a member of the connexin gene family. The encoded protein is a component of gap junctio ...
'', ''
GRHL2'', ''
GRXCR1'', ''
HGF'', ''
LHFPL5'', ''
LOXHD1'', ''
LRTOMT'', ''
MARVELD2
MARVEL domain-containing protein 2 is a protein that in humans is encoded by the ''MARVELD2'' gene
In biology, the word gene (from , ; "... Wilhelm Johannsen coined the word gene to describe the Mendelian units of heredity..." meaning ''ge ...
'', ''
MIR96'', ''
MYH14'', ''
MYH9'', ''
MYO1A'', ''
MYO3A
Myosin-IIIa is a protein that in humans is encoded by the ''MYO3A'' gene
In biology, the word gene (from , ; "... Wilhelm Johannsen coined the word gene to describe the Mendelian units of heredity..." meaning ''generation'' or ''birth'' or ...
'', ''
OTOA
Otoancorin is a protein found in the vertebrate inner ear, on the sensory epithelia where it connects to the gel matrix.
Otoancorin is found in the cochlea, utricule, saccule, and under the cupulae on the surface of apical dells in the sensory ...
'', ''
PJVK'', ''
POU4F3'', ''
PRPS1'', ''
PTPRQ'', ''
RDX'', ''
SERPINB6
Serpin B6 is a protein that in humans is encoded by the ''SERPINB6'' gene.
See also
* Serpin
References
Further reading
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
External links
* The MEROPS online database for peptidases and their inhibitorsI04 ...
'', ''
SIX1'', ''
SLC17A8'', ''
TPRN'', ''
TRIOBP
TRIO and F-actin-binding protein is a protein that in humans is encoded by the ''TRIOBP'' gene.
This gene encodes a protein that interacts with Trio, which is involved with neural tissue development and in controlling actin cytoskeleton organiza ...
'', ''
SLC26A5
Prestin is a protein that is critical to sensitive hearing in mammals. It is encoded by the ''SLC26A5'' (solute carrier anion transporter family 26, member 5) gene.
Prestin is the motor protein of the outer hair cells of the inner ear of the mamm ...
'', and ''
WHRN''.
The causes of nonsyndromic deafness can be complex. Researchers have identified more than 30 genes that, when mutated, may cause nonsyndromic deafness; however, some of these genes have not been fully characterized. Many genes related to deafness are involved in the development and function of the inner ear. Gene mutations interfere with critical steps in processing sound, resulting in hearing loss. Different mutations in the same gene can cause different types of hearing loss, and some genes are associated with both syndromic and nonsyndromic deafness.
In many families, the gene(s) involved have yet to be identified.
Deafness can also result from environmental factors or a combination of genetic and
environmental factors, including certain medications, peri-natal infections (infections occurring before or after birth), and exposure to loud noise over an extended period.
Types include:
Diagnosis
Treatment
Treatment is supportive and consists of management of manifestations. User of hearing aids and/or cochlear implant, suitable educational programs can be offered. Periodic surveillance is also important.
Epidemiology
About 1 in 1,000 children in the United States is born with profound deafness. By age 9, about 3 in 1,000 children have hearing loss that affects the activities of daily living. More than half of these cases are caused by genetic factors. Most cases of genetic deafness (70% to 80%) are nonsyndromic; the remaining cases are caused by specific genetic syndromes. In adults, the chance of developing hearing loss increases with age; hearing loss affects half of all people older than 80 years.
References
Further reading
* In
* In
* In
* In
* In
External links
{{DEFAULTSORT:Nonsyndromic Deafness
Channelopathies
Mitochondrial diseases
Deafness